Ionis Pharmaceuticals, Inc. (IONS)
54.21
-1.44
(-2.59%)
USD |
NASDAQ |
Sep 11, 16:00
54.41
+0.20
(+0.37%)
After-Hours: 20:00
Ionis Pharmaceuticals Price to Book Value : 20.42 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 20.42 |
| September 10, 2026 | 20.96 |
| September 09, 2026 | 21.10 |
| September 08, 2026 | 21.36 |
| September 04, 2026 | 21.88 |
| September 03, 2026 | 21.90 |
| September 02, 2026 | 23.10 |
| September 01, 2026 | 22.56 |
| August 31, 2026 | 22.74 |
| August 28, 2026 | 23.00 |
| August 27, 2026 | 23.52 |
| August 26, 2026 | 23.87 |
| August 25, 2026 | 23.94 |
| August 24, 2026 | 23.37 |
| August 21, 2026 | 22.50 |
| August 20, 2026 | 22.13 |
| August 19, 2026 | 22.90 |
| August 18, 2026 | 22.46 |
| August 17, 2026 | 22.08 |
| August 14, 2026 | 21.56 |
| August 13, 2026 | 21.04 |
| August 12, 2026 | 21.29 |
| August 11, 2026 | 20.88 |
| August 10, 2026 | 21.45 |
| August 07, 2026 | 21.30 |
| Date | Value |
|---|---|
| August 06, 2026 | 20.52 |
| August 05, 2026 | 20.41 |
| August 04, 2026 | 20.74 |
| August 03, 2026 | 20.52 |
| July 31, 2026 | 19.50 |
| July 30, 2026 | 20.07 |
| July 29, 2026 | 20.36 |
| July 28, 2026 | 20.83 |
| July 27, 2026 | 21.08 |
| July 24, 2026 | 21.30 |
| July 23, 2026 | 21.04 |
| July 22, 2026 | 20.34 |
| July 21, 2026 | 20.11 |
| July 20, 2026 | 19.94 |
| July 17, 2026 | 20.49 |
| July 16, 2026 | 20.59 |
| July 15, 2026 | 20.62 |
| July 14, 2026 | 20.69 |
| July 13, 2026 | 21.38 |
| July 10, 2026 | 21.94 |
| July 09, 2026 | 24.21 |
| July 08, 2026 | 31.81 |
| July 07, 2026 | 32.52 |
| July 06, 2026 | 31.33 |
| July 02, 2026 | 30.81 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| Biogen, Inc. | 1.702 |
| BridgeBio Pharma, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 6.449 |
| Arrowhead Pharmaceuticals, Inc. | 25.12 |
Price to Book Value Related Metrics
| PS Ratio | 10.11 |
| PEG Ratio | -0.1783 |
| Price | 54.21 |
| Earnings Yield | -6.41% |
| Market Cap | 8.979B |
| PEGY Ratio | -0.1783 |